SAFETY AND EFFICACY OF IPTACOPAN IN ADOLESCENT PATIENTS WITH IDIOPATHIC (PRIMARY) IMMUNE-COMPLEX-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/024fe01af00007ffc712e8fbc9b1afb1.pdf

Abstract Title

First Name *

Nicholas

Last Name *

Webb

Co-author 1

David Kavanagh David.Kavanagh@newcastle.ac.uk Newcastle upon Tyne Hospitals NHS Foundation Trust National Renal Complement Therapeutics Centre Newcastle upon Tyne

Co-author 2

Andrew S Bomback asb68@cumc.columbia.edu Columbia University College of Physicians and Surgeons Division of Nephrology New York

Co-author 3

Richard J H Smith richard-smith@uiowa.edu Carver College of Medicine, University of Iowa Molecular Otolaryngology and Renal Research Laboratories and the Departments of Internal Medicine and Pediatrics Lowa City

Co-author 4

UdayKiran Veldandi uday_kiran.veldandi@novartis.com Novartis HC Pvt Ltd Global Drug Development Hyderabad

Co-author 5

Yaqin Wang yaqin.wang@novartis.com Novartis Pharmaceuticals Corporation Global Drug Development East Hanover, NJ

Co-author 6

Matthias Meier matthias.meier@novartis.com Novartis Pharma AG Global Drug Development Basel

Co-author 7

Marina Vivarelli marina.vivarelli@opbg.net Bambino Gesù Children's Hospital Division of Nephrology and Dialysis, Department of Pediatric Subspecialties Rome

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos